Epirubicin plus medroxyprogesterone as second-line treatment of advanced prostatic cancer. A study by the Italian Trials in Medical Oncology Group. [electronic resource]
Producer: 19950614Description: 239-44 p. digitalISSN:- 0277-3732
- Aged
- Ambulatory Care
- Bone Neoplasms -- drug therapy
- Drug Synergism
- Drug Therapy, Combination
- Epirubicin -- administration & dosage
- Heart Failure -- chemically induced
- Humans
- Male
- Medroxyprogesterone Acetate -- administration & dosage
- Middle Aged
- Neoplasms, Hormone-Dependent -- drug therapy
- Pain -- drug therapy
- Pain Measurement
- Palliative Care
- Prostatic Neoplasms -- drug therapy
- Survival Analysis
No physical items for this record
Publication Type: Clinical Trial; Journal Article; Multicenter Study
There are no comments on this title.
Log in to your account to post a comment.